Iovance Biotherapeutics Stock Analysis
| IOVA Stock | USD 5.57 0.23 4.31% |
Iovance Biotherapeutics is undervalued with Real Value of 10.04 and Hype Value of 5.61. The main objective of Iovance Biotherapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Iovance Biotherapeutics is worth, separate from its market price. There are two main types of Iovance Biotherapeutics' stock analysis: fundamental analysis and technical analysis.
The Iovance Biotherapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Iovance Biotherapeutics' ongoing operational relationships across important fundamental and technical indicators.
Iovance |
Iovance Stock Analysis Notes
About 90.0% of the company shares are owned by institutional investors. The book value of Iovance Biotherapeutics was currently reported as 2.54. The company recorded a loss per share of 1.48. Iovance Biotherapeutics had not issued any dividends in recent years. The entity had 1:100 split on the 26th of September 2013. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patients immune system to eradicate cancer cells. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Iovance Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 319 people. To learn more about Iovance Biotherapeutics call Esq JD at 650 260 7120 or check out https://www.iovance.com.Iovance Biotherapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Iovance Biotherapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Iovance Biotherapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Iovance Biotherapeutics generated a negative expected return over the last 90 days | |
| Iovance Biotherapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 1.19 M. Net Loss for the year was (444.04 M) with profit before overhead, payroll, taxes, and interest of 8.04 M. | |
| Iovance Biotherapeutics currently holds about 424.46 M in cash with (361.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69. | |
| Iovance Biotherapeutics has a very weak financial position based on the latest SEC disclosures | |
| Over 90.0% of the company shares are owned by institutional investors |
Iovance Biotherapeutics Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Iovance Biotherapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Iovance Biotherapeutics Thematic Classifications
In addition to having Iovance Biotherapeutics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
Iovance Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.7 B.Technical Drivers
As of the 17th of February 2025, Iovance Biotherapeutics retains the Standard Deviation of 3.59, market risk adjusted performance of (3.05), and Risk Adjusted Performance of (0.10). Iovance Biotherapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Iovance Biotherapeutics Price Movement Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Iovance Biotherapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Iovance Biotherapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Iovance Biotherapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Iovance Biotherapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Iovance Biotherapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Iovance Biotherapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Iovance Biotherapeutics Outstanding Bonds
Iovance Biotherapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Iovance Biotherapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Iovance bonds can be classified according to their maturity, which is the date when Iovance Biotherapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Iovance Biotherapeutics Predictive Daily Indicators
Iovance Biotherapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Iovance Biotherapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Iovance Biotherapeutics Forecast Models
Iovance Biotherapeutics' time-series forecasting models are one of many Iovance Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Iovance Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Iovance Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Iovance Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Iovance shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Iovance Biotherapeutics. By using and applying Iovance Stock analysis, traders can create a robust methodology for identifying Iovance entry and exit points for their positions.
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patients immune system to eradicate cancer cells. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Iovance Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Iovance Biotherapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |